Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Clinical Neuropharmacology|October 23, 1997
The treatment of comorbid premature ejaculation and panic disorder with fluoxetineS Kindler, O T Dolberg, H Cohen, et al.Clinical Neuropharmacology|May 14, 1998
Clozapine for the treatment of agitated-depressed patients with cognitive impairment: a report of three casesN Nacasch, O T Dolberg, S Hirschmann, et al.Biological Psychiatry|April 3, 1999
Chronic treatment with repetitive transcranial magnetic stimulation inhibits seizure induction by electroconvulsive shock in ratsA Fleischmann, S Hirschmann, O T Dolberg, et al.Schizophrenia Research|October 12, 2001
Phospholipid patterns of erythrocytes in schizophrenia: relationships to symptomatologyA M Ponizovsky, I Modai, Y Nechamkin, et al.The British Journal of Psychiatry : the Journal of Mental Science|March 31, 1998
Sulpiride augmentation in people with schizophrenia partially responsive to clozapine. A double-blind, placebo-controlled studyR Shiloh, Z Zemishlany, D Aizenberg, et al.The Journal of ECT|January 1, 1999
Labetalol does not lengthen asystole during electroconvulsive therapyP N Dannon, I Iancu, S Hirschmann, et al.Journal of Clinical Psychopharmacology|September 23, 2000
Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trialS Hirschmann, P N Dannon, I Iancu, et al.Planta Medica|February 1, 1987
Further eudesmane derivatives from verbesina speciesJ Jakupovic, E Ellmauerer, Y Jia, et al.European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|May 4, 2000
Pindolol augmentation in treatment-resistant obsessive compulsive disorder: a double-blind placebo controlled trialP N Dannon, Y Sasson, S Hirschmann, et al.The Journal of ECT|December 30, 1999
Aminophylline increases seizure length during electroconvulsive therapyL Stern, P N Dannon, S Hirschmann, et al.Pageof 10